| Stage | EMN | % of rev | DOW | % of rev | Gap · A − B |
|---|---|---|---|---|---|
| Revenue | $2.4B | 100.00% | $11.3B | 100.00% | DOW ×4.72 |
| Gross profit | $532M | 22.31% | $1.4B | 12.23% | EMN +10.1pp |
| Operating income | $305M | 12.79% | $741M | 6.58% | EMN +6.2pp |
| Pre-tax income | $249M | 10.44% | $642M | 5.70% | EMN +4.7pp |
| Net income | $253M | 10.61% | $525M | 4.66% | EMN +5.9pp |
| Stage | EMN | DOW | Gap · A − B |
|---|---|---|---|
| Revenue | $2.4B100.00% | $11.3B100.00% | DOW ×4.72 |
| Gross profit | 22.31%$532M | 12.23%$1.4B | EMN +10.1pp |
| Operating income | 12.79%$305M | 6.58%$741M | EMN +6.2pp |
| Pre-tax income | 10.44%$249M | 5.70%$642M | EMN +4.7pp |
| Net income |
| 10.61%$253M |
| 4.66%$525M |
| EMN +5.9pp |